Cargando…

Acquired Melanonychia in Chilean Patients with Essential Thrombocythemia Treated with Hydroxyurea: A Report of 7 Clinical Cases and Review of the Literature

Longitudinal melanonychia has been associated with a range of drugs, especially chemotherapeutic agents. We report 7 cases of melanonychia associated with the use of hydroxycarbamide for essential thrombocythemia. Of a patient population of 27, 7 (26%) developed melanonychia over a period of 2–7 yea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murray, Nigel P., Tapia, Pablo, Porcell, Jose, Echavarria, Maximiliano, Suazo, Hernán
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3582049/ https://www.ncbi.nlm.nih.gov/pubmed/23476797 http://dx.doi.org/10.1155/2013/325246

Ejemplares similares

Melanonychia and skin hyperpigmentation with hydroxyurea therapy
por: Koley, Sankha, et al.
Publicado: (2010)

Hydroxyurea-induced Tongue Hypermelanosis and Transverse Melanonychia
por: Neculiseanu, Elvira, et al.
Publicado: (2019)

Recurrent melanonychia on multiple nails and alopecia induced by hydroxyurea therapy
por: Sun, Yifang, et al.
Publicado: (2022)

An Ulceronecrotic Foot Lesion in a Patient with Essential Thrombocythemia: Successful Treatment with Hydroxyurea
por: Kato, Tokue, et al.
Publicado: (2012)

Successful Management of Hydroxyurea-induced Leg Ulcers in Essential Thrombocythemia: Report of 3 Cases
por: Rahal, Jihane Abou, et al.
Publicado: (2013)

Prognostic value of modified criteria for hydroxyurea resistance or intolerance in patients with high‐risk essential thrombocythemia
por: Park, Young Hoon, et al.
Publicado: (2023)

PB2215: HYDROXYUREA-INDUCED CUTANEUS ADVERSE EVENTS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A SINGLE-CENTER EXPERIENCE
por: Peña, Amaia Lopez, et al.
Publicado: (2023)

Melanonychia
por: Jefferson, Julie, et al.
Publicado: (2012)

Melanonychia
por: Metzner, Michael J., et al.
Publicado: (2015)

Rapid and robust reversion to essential thrombocythemia on treatment with Decitabine in a case of hydroxyurea‐induced t‐MDS/AML
por: Horton, Joshua D., et al.
Publicado: (2015)

A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia
por: Mascarenhas, John, et al.
Publicado: (2022)

P1046: TREATMENT COMPARISON OF HYDROXYUREA VS RUXOLITINIB IN ESSENTIAL THROMBOCYTHEMIA (ET): A MATCHED COHORT ANALYSIS
por: Grunwald, Michael, et al.
Publicado: (2023)

Essential thrombocythemia
por: Brière, Jean B
Publicado: (2007)

Ruxolitinib for essential thrombocythemia?
por: Bose, Prithviraj, et al.
Publicado: (2017)

Dynamics of mutations in patients with essential thrombocythemia treated with imetelstat
por: Leibundgut, Elisabeth Oppliger, et al.
Publicado: (2020)

Melanonychia Secondary to Long-Term Treatment with Hydroxycarbamide: An Essential Thrombocytosis Case
por: Malkan, Umit Yavuz, et al.
Publicado: (2015)

Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding
por: Awada, Hassan, et al.
Publicado: (2020)

The Importance of Dermatoscopy for the Diagnosis of Melanonychia
por: IANOȘI, SL, et al.
Publicado: (2019)

Melanonychia: Etiology, Diagnosis, and Treatment
por: Singal, Archana, et al.
Publicado: (2020)

Dermoscopic findings of fungal melanonychia
por: Elmas, Ömer Faruk, et al.
Publicado: (2020)

Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea
por: Renso, Rossella, et al.
Publicado: (2018)

S168: PELABRESIB (CPI-0610) MONOTHERAPY IN PATIENTS WITH HIGH-RISK ESSENTIAL THROMBOCYTHEMIA REFRACTORY OR INTOLERANT TO HYDROXYUREA: PRELIMINARY RESULTS FROM MANIFEST STUDY
por: Passamonti, Francesco, et al.
Publicado: (2023)

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis
por: Takasaki, Kazuki, et al.
Publicado: (2021)

Emerging treatments for essential thrombocythemia
por: Okoli, Steven, et al.
Publicado: (2011)

Thromboembolic complication in Essential Thrombocythemia
por: Mozaheb, Zahra
Publicado: (2012)

Essential thrombocythemia: Busulphan revisited
por: Koduri, Prasad R.
Publicado: (2016)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

Essential Thrombocythemia in Children and Adolescents
por: Putti, Maria Caterina, et al.
Publicado: (2021)

Mutations and thrombosis in essential thrombocythemia
por: Guglielmelli, Paola, et al.
Publicado: (2021)

Consensus on melanonychia nail plate dermoscopy
por: Chiacchio, Nilton Di, et al.
Publicado: (2013)

Hyperpigmented macules in the oral mucosa and melanonychia
por: Killpack, Luke, et al.
Publicado: (2018)

Melanonychia – Clues for a Correct Diagnosis
por: Gradinaru, Teodora C, et al.
Publicado: (2020)

Moyamoya syndrome in an adult with essential thrombocythemia
por: Lazzaro, Marc A., et al.
Publicado: (2011)

Essential thrombocythemia: Rare cause of chorea
por: Venkatesan, Eswaradass Prasanna, et al.
Publicado: (2014)

Mutant calreticulin causes essential thrombocythemia
por: Shimoda, Kazuya, et al.
Publicado: (2017)

Essential thrombocythemia treatment algorithm 2018
por: Tefferi, Ayalew, et al.
Publicado: (2018)

Essential Thrombocythemia Presenting as Paraneoplastic Glomerulonephritis
por: Abdulla, M. C., et al.
Publicado: (2018)

Imatinib-induced Transverse Melanonychia: An Unusual Presentation
por: Das, Anupam, et al.
Publicado: (2015)

Use of Nail Dermoscopy in the Management of Melanonychia: Review
por: Starace, Michela, et al.
Publicado: (2019)

Longitudinal melanonychia in childhood: a great challenge()
por: Morato, Isabela Boechat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b77gfljplr0h27hb1tivim7h44